NCT04965246

Brief Summary

The Trial Assessing Light-Intensity Exercise on the Health of Older Breast Cancer Survivors pilot randomized controlled trial aims to evaluate the efficacy of a home-based, light-intensity physical activity intervention among 56 obese, older adult breast cancer survivors, in comparison to a usual care control condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 16, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

November 22, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2024

Completed
Last Updated

January 15, 2025

Status Verified

December 1, 2024

Enrollment Period

2.6 years

First QC Date

July 7, 2021

Last Update Submit

January 13, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Markers of inflammation: C-reactive protein

    A cytokine multiplex will assess markers of inflammation, including C-reactive protein

    Baseline

  • Markers of inflammation: C-reactive protein

    A cytokine multiplex will assess markers of inflammation, including C-reactive protein

    15 weeks

Secondary Outcomes (45)

  • Markers of inflammation-Interleukin 6

    Baseline

  • Markers of inflammation-Interleukin 6

    15 weeks

  • Markers of inflammation-Tumor Necrosis Factor Alpha

    Baseline

  • Markers of inflammation-Tumor Necrosis Factor Alpha

    15 weeks

  • The Functional Assessment of Cancer Therapy-Cognitive Function-Perceived Cognitive Impairments

    Baseline

  • +40 more secondary outcomes

Study Arms (2)

Physical activity

EXPERIMENTAL

the physical activity intervention will be structured to increase light-intensity aerobic physical activity, to achieve a total of 150 minutes per week. The intervention will also include weekly support calls from research staff to improve compliance to physical activity

Behavioral: Physical Activity

Usual care

OTHER

Participants randomized to the usual care control group will serve as the control group for 15 weeks, and receive no intervention during this time.

Other: Usual Care

Interventions

The physical activity program will focus on increasing physical activity, starting with a target of 100 minutes per week. The session durations will build over time to 150 minutes per week. Participants will be instructed to walk, or engage in other forms of light-intensity physical activity to achieve these goals. Participants will be instructed on the use of the ratings of perceived exertion scale (6-20). As the participants' health and fitness status improves, frequency, intensity, and session duration will be modified accordingly during weekly support calls. As participants will enter the study engaging in varying levels of physical activity, goals will be responsive to the most recent week's achieved minutes.

Physical activity

Participants in the usual care group will receive no intervention

Usual care

Eligibility Criteria

Age65 Years - 84 Years
Sexfemale
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Female
  • Age 65-84 years
  • years post-breast cancer treatment
  • Body mass index ≥30
  • ≥1 drink per week over the last month
  • ≥21 on the Telephone Interview For Cognitive Status
  • ≤7 on the Alcohol Use Disorder Identification Test
  • Fluent in written and spoken English
  • Must be able to provide and understand informed consent
  • Primary physician approval

You may not qualify if:

  • Body mass index \<30
  • \< 21 on the Telephone Interview for Cognitive Status
  • \>7 on the Alcohol Use Disorder Inventory Test
  • Other neurological or major psychiatric disorders
  • Significant heart or lung disease
  • Limited life expectancy
  • Other factors that could potentially limit ability to participate fully in the intervention
  • Self-reporting achieving over 150 minutes of moderate-to-vigorous physical activity per week.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

MeSH Terms

Conditions

InflammationCognitive DysfunctionAnxiety DisordersAlcohol Drinking

Interventions

Exercise

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental DisordersDrinking BehaviorBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Kathryn Schmitz, PhD

    Milton S. Hershey Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 7, 2021

First Posted

July 16, 2021

Study Start

November 22, 2021

Primary Completion

July 8, 2024

Study Completion

July 8, 2024

Last Updated

January 15, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations